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N-acetyl cysteineAdvanced glycation end products (AGEs) result from non-enzymatic glycation of proteins and cause cellular
oxidative stress in a nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent manner.
Due to these effects, AGEs are implicated as a causal factor in diabetic complications. Several antioxidants, in-
cluding vitamin E, improve cell viability and diminish markers of oxidative damage in cells exposed to AGEs.
However, vitamin E has been studied in cell culture systems with primary focus on apoptosis and lipid perox-
idation, while its inﬂuences on AGE-induced protein and DNA oxidation, intracellular antioxidant status and
cell morphology remain largely unknown. Here, we verify the suppression of AGE-induced cell death and
lipid peroxidation by 200 μMα-tocopherol in SH-SY5Y cells. We report the partial inhibition of DNA oxidation
and a decrease in protein carbonyl formation by α-tocopherol with no effects on intracellular GSH concentra-
tions. We observed that 2 mM N-acetyl cysteine (NAC) also had a suppressive effect on DNA and protein ox-
idation, but unlike α-tocopherol, it caused a marked increase in intracellular GSH. Finally, we compared the
ability of both antioxidants to maintain neurites in SH-SY5Y cells and found that α-tocopherol had no effect
on neurite loss due to AGEs, while NAC fully maintained cell morphology. Thus, while α-tocopherol sup-
pressed AGE-induced macromolecule damage, it was ineffective against neurite degeneration. These results
may implicate thiol oxidation and maintenance as a major regulator of neurite degeneration in this model.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Diabetes is a prevalent disease hallmarked by dysregulation of
blood glucose concentrations and subsequent damage to tissues like
the eyes, nerves, and kidneys. Cellular damage is in large part mediat-
ed by an enhanced generation of reactive oxygen species (ROS) [1].
When concentrations of ROS exceed that which can be effectively
neutralized by endogenous antioxidant defenses, a state of oxidative
stress arises. The mechanisms by which hyperglycemia causes intra-
cellular stress include an increase in mitochondria-generated super-
oxide radicals [2,3]. High glucose further potentiates oxidative
damage in diabetes by compromising cellular redox status via deple-
tion of NADPH and thus GSH through the polyol pathway [2].
Oxidative damage is also created from the products of nonenzy-
matic protein glycation termed as advanced glycation end products
(AGEs). AGEs induce a range of cellular effects, mostly through pro-
tein cross-link formation and through binding to the receptor for ad-
vanced glycation end products (RAGE) [4]. RAGE is a transmembranenced glycation end products;
ids; RA, retinoic acid; α-T, α-
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l rights reserved.receptor of the immunoglobulin superfamily that has several poten-
tial ligands, each of which can induce different downstream effects
ranging from neurite outgrowth and cell survival [5,6] to cell prolifer-
ation to apoptosis, depending on the speciﬁc ligand and the RAGE do-
main with which it interacts [7]. In diabetes, the binding of AGEs to
RAGE initiates many of the downstream effects observed in models
of the disease, including the activations of NADPH oxidase, p21,
RAS, p38 MAPK, and NF-κB [8].
Experimental results suggest that AGEs have a causative role in
several outcomes of tissue damage in diabetes, including progression
of diabetes-associated nephropathy [9,10], retinal degeneration
[11,12], and neuropathy [13,14]. In vitro studies and cell culture
models of diabetic neuropathy using dorsal root ganglia neurons
[15], human NT2 neurons [16], and SH-SY5Y cells [17] conﬁrm that
AGEs induce superoxide radical generation in neuronal-derived cells
through activation of NADPH oxidase in a PKCδ-dependent manner
[16,17]. These actions result in an accumulation of oxidative damage
markers like malondialdehyde (MDA) and outcomes like RAGE upre-
gulation, DNA fragmentation, and apoptosis [15,18]. Antioxidants
such as EGCG [18], ginkgo biloba extract [16], α-lipoic acid [15,19],
and N-acetyl-cysteine (NAC) [19] suppress AGE-induced macromole-
cule oxidation and its downstream effects.
Vitamin E is a potent chain-breaking antioxidant that resides in
cellular membranes and maintains their integrity through inhibition
of lipid peroxidation. Vitamin E also slows protein glycation in vitro
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a contributor to AGE synthesis [21]. However, the relevance of these
ﬁndings to human diabetics is unclear, as some evidence supports
no effect of vitamin E supplementation on protein glycation in vivo
[22]. Despite this conﬂict, the data suggest that a protective role exists
for vitamin E against AGEs and their downstream damage. Vitamin E
partially prevents endothelial cell proliferation due to AGE-BSA [23]
and prevents diabetes-associated PKC-β2 upregulation, resulting in
improved mesenteric artery vasodilation [22]. Vitamin E suppresses
AGE-induced NF-κB activation [24] and cytokine expression in
mesangial cells [24,25]. In human NT2 neurons, vitamin E decreases
ROS production, MDA generation, RAGE upregulation, and apoptosis
caused by incubation with ribose-glycated FBS [16].
The role of vitamin E has been evaluated most frequently in AGE-
induced changes in cell proliferation, apoptosis, ROS formation, and in
the formation of lipid peroxidation markers like MDA. However, the
role of vitamin E is less clear with regard to changes in intracellular
antioxidant status, cell morphology, and the oxidation of protein
and DNA that result from AGE exposure. Differences in these effects
compared to those of a prototypical thiol antioxidant would provide
insight into the mechanisms of protection against AGEs. Contrasting
effects of these antioxidants on cellular damage may highlight the op-
timum chemical properties for protection against AGEs. In this study,
we investigated the effects of vitamin E and NAC on AGE-induced ox-
idative damage to determine their separate protective capabilities in
SH-SY5Y cells.
2. Materials and methods
2.1. Materials
Dulbecco's Modiﬁed Eagle Medium (DMEM), Ham's F12 medium,
penicillin–streptomycin, and fetal bovine serum (FBS) were obtained
from Invitrogen (Carlsbad, CA). Fatty acid-free bovine serum albumin
(BSA) and glycolaldehyde were obtained from Sigma (St. Louis, MO).
SH-SY5Y cells were obtained from ATCC (Manassas, VA).
2.2. Preparation of AGE-BSA
AGE-BSA was prepared as previously reported [26] with modiﬁca-
tions. 5 mg/ml fatty acid-free BSA was incubated with 33 mM glyco-
laldehyde in PBS for 20 h at 37 °C. Control BSA was incubated under
the same conditions but without glycolaldehyde. We found that
excessive cross-linking occurred when BSA was incubated with glyco-
laldehyde for any longer than 36 h, resulting in a non-cytotoxic pro-
tein product (data not shown). BSA and AGE-BSA were dialyzed
against PBS for 3 days at 4 °C and sterilized by vacuum ﬁltration
through a polyethersulfone ﬁlter (VWR, West Chester, PA). AGE-
modiﬁcation was conﬁrmed by an approximately 40-fold increase in
absorbance at 340 nm, a 5.2-fold increase in ﬂuorescence at 335 nm
(excitation) and 420 nm (emission), and further by western blot
with an anti-AGE antibody (Millipore) (data not shown). Protein
concentrations were veriﬁed using a Pierce BCA protein assay kit.
Aliquots were frozen at −20 °C.
2.3. SH-SY5Y cell culture and treatments
SH-SY5Y cells were grown and cultured in DMEM supplemented
with 10% FBS and 1% penicillin–streptomycin. Cells were maintained
at 37 °C and in 7% CO2. To encourage neurite outgrowth, SH-SY5Y
cells were treated with 10 μM RA in DMEM:F12 (1:1) supplemented
with 1% FBS for 3–5 days. Cells were then exposed to 1–1.25 mg/ml
BSA, AGE-BSA, or an equivalent dilution of PBS for 72 h. Cells receiv-
ing α-tocopherol (diluted in ethanol) or NAC (diluted in PBS) treat-
ments were pretreated for 24 h before the addition of AGE-BSA,
BSA, or PBS. The antioxidant treatments were then refreshed withAGE-BSA, BSA, or PBS. In experiments directly comparing AGE-BSA±
α-tocopherol or NAC, all treatments included 0.1% ethanol and PBS in
an effort to control for vehicle effects.
2.4. Effect of AGE-BSA on cell viability
The viability of SH-SY5Y cells following treatments was measured
using the MTT assay [27]. MTT (3-[4,5-dimethyl-2-thiazolyl]-2,5-
diphenyl-2H-tetrazolium bromide, Sigma Aldrich) is a yellow com-
pound that when reduced by functioning mitochondria, produces
purple formazan crystals that can bemeasured spectrophotometrical-
ly. MTT was dissolved in PBS for a ﬁnal concentration of 5 mg/ml and
then diluted in cell culturemedia for a ﬁnal concentration of 0.5 mg/ml.
Cells were incubated with MTT for 3 h, after which the resulting purple
formazan crystals were solubilized by 20% SDS in 50% dimethylforma-
mide (DMF). The absorbance of each sample was then read at 570 nm
as a test wavelength and 690 nm as a reference wavelength. Data are
expressed as percent of PBS controls.
2.5. Effect of AGE-BSA on cell morphology
SH-SY5Y cells were plated in a 6-well plate and treated with PBS,
BSA, or AGE-BSA with and without NAC and α-tocopherol. Changes in
cell morphology were documented using differential interference
contrast (DIC) microscopy on an Olympus 1X70 inverted microscope
with an attached Olympus DP70 digital camera system. Separate im-
ages were recorded for 10, 20, and 40× objectives. At least 4 random
ﬁelds of observation were recorded per treatment. Images taken at
40× were then opened using the Image J program, and neurites
were quantiﬁed in a blind manner for at least 4 images from 3 inde-
pendent samples. Data are expressed as number of neurites per cell.
2.6. Vitamin E measurement
To quantify cellular vitamin E status, cells were washed with PBS
and scraped into PBS: ethanol+1 mg/ml BHT (1:1) with δ-tocopherol
as an internal standard. Tocopherols were extracted twicewith hexane.
The hexane layerswere combined in a new tube and evaporated to dry-
ness, and tocopherols were resuspended in 250 μl ethanol+1 mg/ml
BHT. Tocopherol content was analyzed by high performance liquid
chromatography (HPLC) with electrochemical detection using an ESA
Coularray system (Chelmsford, MA). A ﬂow rate of 1 ml/min was
used with 50% mobile phase A (methanol:isopropanol:ammonium
acetate buffer 1.0 M, pH 4.36, 78:20:2) and 50% mobile phase B
(methanol:isopropanol:ammonium acetate buffer 1.0 M, pH 4.36,
59:40:1). The α-tocopherol eluted at approximately 7.6 min and had a
predominant peak at 200 mV, and δ-tocopherol eluted at 6.1 min with
its predominant peak at 600 mV.
2.7. GSH measurement
To measure intracellular GSH concentrations, cells were scraped
into PBS, centrifuged, and the pellet resuspended in 5%metaphospho-
ric acid with 100 μM EDTA. Cells were lysed by several freeze/thaw
cycles. Protein was precipitated by centrifugation and later quantiﬁed
using the Pierce BCA protein assay kit. The supernatant was ﬁltered
and analyzed by HPLC coupled with electrochemical detection. An
ESA Coularray system was used with 5% mobile phase B (20% metha-
nol, 30% mobile phase A, 50% acetonitrile) in mobile phase A (50 mM
sodium phosphate, pH 3). GSH eluted at approximately 4.6 min, with
the predominant peak at 900 mV.
2.8. Lipid peroxidation
To measure total MDA, 6.0×106 SH-SY5Y cells that had been ex-
posed to treatments with and without antioxidants for 48 h were
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ethanol was added to cells to prevent artifactual generation of lipid
peroxidation products. Cells were lysed by freeze/thaw cycles and
underwent acid hydrolysis by HCl at 60 °C for 80 min to free conju-
gated MDA. 10% trichloroacetic acid was then added and proteins
were precipitated and quantiﬁed using Pierce BCA total protein assay.
The supernatant was combined at a 1:1 ratio with 0.67% thiobarbituric
acid and incubated at 90 °C for 30 min. After cooling, aliquots were
measured for ﬂuorescence at 530 nm (excitation) and 550 nm
(emission) on a SpectraMax Gemini XS ﬂuorescence plate reader
(Molecular Devices, Sunnyvale, CA). 1,1,3,3-tetramethoxypropane was
used as a standard.
Under conditions of oxidative stress, percentages of polyunsatu-
rated fatty acids (PUFAs) in tissue often decline due to peroxidation.
To measure changes in PUFA concentrations, extraction of total lipids
was performed using a slightly modiﬁed method of Muller et al. [28].
SH-SY5Y cells were treated appropriately for 72 h and then washed
twice with ice-cold PBS. Cells were scraped into PBS, centrifuged,
and the cell pellet was resuspended in DDI water. Total cell lipids
were extracted three times using chloroform/methanol (2/1, v/v+
0.001% BHT). Organic phases were combined in another tube and
evaporated to dryness under nitrogen. Lipids were methylated in
two steps. First, lipids were transmethylated using 5% potassium
methylate solution in methanol for 30 min at 60 °C. Then, 1 N metha-
nolic sulfuric acid was added and after vortexing, the tubes were in-
cubated at 60 °C for 15 min. Saturated NaCl solution in water and n-
hexane were added and the tubes were vortexed to bring the fatty
acid methyl esters into the hexane phase. After centrifugation, the
hexane layer was transferred to a new tube and the hexane extraction
was repeated. Hexane layers were combined and evaporated to dry-
ness under nitrogen. Fatty acid methyl esters were resuspended in
500 μl n-hexane and analyzed on a Varian 3900 Gas Chromatograph.
2.9. Protein carbonyls
SH-SY5Y cells were treated for 72 h with PBS, BSA, or AGE-BSA±
antioxidants. The cells were then washed with ice-cold PBS and
scraped into RIPA buffer containing DTT. Insoluble protein fractions
were separated by centrifugation and the protein concentration of
the soluble portion was quantiﬁed using the Pierce BCA protein
assay kit. Each sample was analyzed for protein carbonyl content
using theOxyblot Protein OxidationDetection Kit (Chemicon, Temecula,
CA) and subsequent western blot. Blots were scanned and analyzed by
UN-SCAN-IT gel 6.1 software (Silk Scientiﬁc, Inc, Orem, Utah), normal-
ized to β-actin expression, and expressed as percent of PBS control.
2.10. DNA oxidation
SH-SY5Y cellswere plated on collagen-coated cover slips (BD Biosci-
ences, San Jose, CA) and treated for 48 h with PBS, BSA, and AGE-BSA±
antioxidants. Cells were then washed several times with PBS and ﬁxed
in 0.5% glutaraldehyde in PBS for 10 min at room temperature. Cells
were rinsed with PBS 3 times and permeabilized with 3 washes in
0.5% Triton X-100 in PBS for 5 min each. Cells were once again washed
3 times in PBS and incubated with a primary antibody raised against
8-hydroxy-2′-deoxyguanosine (Trevigen, Gaithersburg, MD) and
then a secondary antibody tagged with Alexa Fluor 488 (Molecular
Probes, Invitrogen, Carlsbad, CA) according to instructions supplied
by Trevigen. Cover slips were mounted with Prolong Gold antifade
reagent with DAPI (Invitrogen) and allowed to cure overnight.
Cover slips were sealed the next morning and kept at room
temperature. Slides were analyzed by confocal microscopy on a
Zeiss LSM 710 microscope (Zeiss, Germany) at 40× with Immersol
W water-immersion ﬂuid (Zeiss). During analysis, random nuclei
were selected blindly, based solely on DAPI ﬂuorescence. These re-
gions were encircled and the mean Alexa Fluor 488 ﬂuorescentintensities within these boundaries were then determined. Approxi-
mately 150 cells in 3 independent experiments were analyzed per
treatment and expressed as a percent of the ﬂuorescent intensity of
PBS-treated cells.
2.11. Statistical analysis
Results are expressed as mean±S.D, except for neurite number,
which is expressed as mean±SEM. All experiments were repeated
independently three times, or more where indicated. Statistical sig-
niﬁcance was determined by ANOVA, except for GSH analysis,
which was analyzed by Student's t test for comparison within treat-
ment groups. Post hoc analysis was performed using Tukey's tests
for multiple comparisons of groups.
3. Results
3.1. Effect of AGE-BSA on cell viability
The goal of this study was to characterize the functions of the lipid
peroxyl radical scavenger vitamin E in inﬂuencing AGE-induced oxida-
tive damage, antioxidant status, and neurite degeneration; the antioxi-
dant NAC served as the positive control. Treatment of SH-SY5Y cells
with AGE-BSA induced a signiﬁcant dose-dependent decrease in cell vi-
ability, whereas control BSA had no negative effect (Fig. 1A). To verify
previous results that antioxidants – including vitamin E – partially sup-
press AGE-induced declines in cell viability, we incubated SH-SY5Y
cells with 1.0 mg/ml AGE-BSA or control BSA or an equivalent dilution
of PBS for 72 h with and without 2.0 mM NAC or 200 μM α-tocopherol.
Our preliminary studies indicated that these concentrations were
appropriate, as the protective effects of α-tocopherol and NAC reached
plateaus at 200 μM and 2 mM respectively (data not shown). AGE-BSA
decreased cell viability approximately 50% over a 72-hour period. Co-
administration of NAC (Fig. 1B) or α-tocopherol (Fig. 1C) improved
viability, approximately 40% and 20% respectively. NAC provided consid-
erable protection against AGE-BSA, as therewas no signiﬁcant difference
between cells treated with AGE-BSA+NAC and cells treated with
control BSA. However, cellular protection provided by α-tocopherol
was not complete, as there was signiﬁcant difference between AGE+
α-tocopherol treated cells and BSA-treated cells. Neither NAC nor α-
tocopherol had any inﬂuence on the viability of PBS or BSA controls.
3.2. Effect of AGE-BSA on cell morphology
RA induces the growth and maintenance of neurites in SH-SY5Y
cells. Because oxidative conditions can cause degeneration of neur-
ites, we tested the effects of AGE-BSA on cell morphology as well as
the inﬂuences that α-tocopherol and NAC have on this process. To ac-
complish this, SH-SY5Y cells were treated and examined by DIC mi-
croscopy. Treatment with AGE-BSA reduced the number of cellular
neurites, while BSA had no effect on neurite density (Fig. 2). Co-
treatment with α-tocopherol did not suppress AGE-induced neurite
degeneration. However, NAC maintained neurite number when ad-
ministered with AGE-BSA. Therefore, NAC and not α-tocopherol
maintained the morphology and structure of neuronal cells in the
presence of AGEs.
3.3. Effect of AGE-BSA and α-tocopherol and NAC on cellular antioxidant
status
Under stress conditions, antioxidant pools may become depleted
due to oxidation. Because of this, antioxidant status is often a useful
marker of cellular stress. To test the effects of α-tocopherol and
NAC on antioxidant status, cellular vitamin E and GSH concentrations
were measured. The concentrations of vitamin E before supplementa-
tion were very low, and these values increased several hundred-fold
Fig. 1. Effects of AGE-BSA and antioxidants on SH-SY5Y viability. Cell viability of SH-
SY5Y cells treated with 0–1.5 mg/ml BSA or AGE-BSA for 72 h (A). Cell viability of
SH-SY5Y cells treated with PBS, BSA, or AGE-BSA±2 mM NAC (B) or 200 μM α-
tocopherol (C) for 72 h. Viability is expressed as absorbance of MTT [570 nm–
690 nm]. Values are expressed as mean±S.D. (n=9–12). Data were analyzed by
ANOVA. ⁎Pb0.05 vs. PBS control, ⁎⁎Pb0.0001 vs. PBS control. Means with superscript
letters that are not the same are signiﬁcantly different (pb0.05).
Fig. 2. Effects of AGE-BSA and antioxidants on cellmorphology. RepresentativeDIC images
of AGE-treated SH-SY5Y cells. SH-SY5Y cells were treated with (A) PBS, (B) BSA, (C) AGE-
BSA, (D) AGE-BSA+200 μMα-tocopherol, and (E) AGE-BSA+2mMNAC for 72 h. Images
of at least 4 random ﬁelds per treatment were captured by DIC microscopy. (F) Neurite
number per cell for SH-SY5Y cells treated with PBS, BSA, AGE-BSA, AGE+200 μM α-
tocopherol, and AGE-BSA+2mM NAC; neurites were quantiﬁed using Neuron J. Bar
values are expressed as mean±SEM. Data were analyzed by ANOVA, and mean values
with superscript letters that are not the same are signiﬁcantly different (pb0.05).
Table 1
Inﬂuence of BSA and AGE-BSA on α-tocopherol levels. Cellular α-
tocopherol concentrations were measured in SH-SY5Y cells treated
with PBS, BSA, or AGE-BSA±200 μM α-tocopherol or 2 mM NAC
for 72 h. Data were analyzed by ANOVA and bar values are expressed
as mean±S.D. (n=3–4). Mean values with superscript letters that
are not the same are signiﬁcantly different (pb0.05).
Treatment α-tocopherol
(nmol/mg protein)
PBS 0.014±0.008a
BSA 0.028±0.020a
AGE-BSA 0.032±0.008a
AGE-BSA+NAC 0.024±0.012a
PBS+αT 8.90±1.62b
BSA+αT 11.4±1.48c
AGE-BSA+αT 12.0±1.82c
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vitamin E concentrations, perhaps because the extremely low con-
centrations of this vitamin did not provide suitable targets for oxida-
tion and subsequent depletion. In PBS-treated cells, α-tocopherol
supplementation signiﬁcantly increased the concentration of this vi-
tamin compared to controls treated with ethanol vehicle alone. Addi-
tionally, AGE-BSA and control BSA both showed signiﬁcantly higher
cellular vitamin E concentrations than the values for PBS treatment
in α-tocopherol-supplemented cells. This ﬁnding might suggest that
BSA enhances cellular vitamin E uptake by functioning in its known
role as a lipid transporter in this cell culture model. It might also sug-
gest that glycation of BSA does not diminish this function.
We also measured the intracellular changes in GSH concentration
in response to AGE-BSA and the antioxidant co-treatments. We found
that AGE-BSA signiﬁcantly decreased intracellular GSH when com-
pared to PBS and BSA controls (Fig. 3). The co-treatment of cells
with α-tocopherol had no inﬂuence on this process as the decline inGSH due to AGE-BSA remained unaltered and the values with and
without α-tocopherol supplementation were not signiﬁcantly differ-
ent. Therefore, α-tocopherol showed no effect on the intracellular
GSH concentration. NAC signiﬁcantly raised intracellular GSH concen-
trations by approximately 30 nmol/mg protein. There was no de-
crease in GSH due to AGE-BSA in NAC-treated cells. Thus, NAC may
be protective against AGEs by increasing intracellular GSH and main-
taining this pool after AGE-BSA administration.
Fig. 3. Effects of AGE-BSA and antioxidants on GSH levels. Intracellular GSH concentra-
tions for SH-SY5Y cells treated with PBS, BSA, or AGE-BSA±200 μM α-tocopherol or
2 mM NAC for 72 h. Data were analyzed by ANOVA to determine differences between
antioxidant treatment groups and Student's t tests were used to compare samples
within those groups. Bar values are expressed as mean±S.D. (n=4). ⁎Pb0.05 vs.
within-treatment PBS and BSA controls when compared by Student's t test,
⁎⁎Pb0.0001 vs. all samples not receiving NAC treatment.
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To examine the accumulation of oxidized products, we next tested
the abilities of α-tocopherol and NAC to suppress AGE-induced oxida-
tive damage to macromolecules. AGE-BSA treatment caused TBARS
levels (expressed in nmol/mg total protein) to rise 17% in comparison
to PBS-treated controls and 25% in comparison to unglycated BSA-
treated controls (Fig. 4A). We then veriﬁed previous results that α-
tocopherol decreases AGE-induced lipid peroxidation [16] by conﬁrm-
ing that vitamin E – and not NAC – suppresses the modest increase in
total intracellular MDA caused by AGE-BSA.
We next examined changes in protein oxidation as a function of
AGE-BSA treatment by measuring total protein carbonyl content.
We found that treatment with AGE-BSA increased total protein
carbonyls in SH-SY5Y cells (Fig. 4B–C). Both α-tocopherol and NAC
suppress this effect of AGEs on total protein oxidation. The level of
8-hydroxy-2′-deoxyguanosine in intact DNA was also assessed as a
marker of DNA oxidation. AGE-BSA signiﬁcantly increased the
amount of this marker, while α-tocopherol partially and NAC
completely suppressed the damage (Fig. 4D).
4. Discussion
In this study, we compared the effects that α-tocopherol and NAC
have on outcomes related to oxidative damage in SH-SY5Y cells ex-
posed to AGEs. We used SH-SY5Y cells as this cell line has been
employed in cell culture models for several neurodegenerative dis-
eases like Parkinson's disease [29] and Alzheimer's disease [30]. SH-
SY5Y cells have also been utilized in models for diabetic neuropathy
wherein the effects of high glucose [31] and AGEs [17,19,32,33]
were tested. Additionally, we chose to use SH-SY5Y cells that had
been pre-treated with RA as this causes sensitization to AGE-
induced stress by increasing the activity of PKCδ and the expression
of p47 phox [17]. SH-SY5Y cells are useful for the evaluation of anti-
oxidants and their relative abilities to ameliorate AGE-induced oxida-
tive damage [18]. Using SH-SY5Y cells, we conﬁrmed previous
ﬁndings that α-tocopherol reduces the cytotoxic effects of AGEs in
neuronal-derived NT2 cells [16].
RAGE signaling induces oxidative damage and apoptosis in dorsal
root ganglia neurons [15] and in cell lines using either NT2 cells [16]
or SH-SY5Y cells [17]. Vitamin E provides cellular protection against
RAGE-mediated stress, the mechanism of which is likely through
the function of the vitamin as a chain-breaking antioxidant againstlipid peroxidation. Indeed, we conﬁrmed that the vitamin E isoform
α-tocopherol suppressed a modest AGE-induced increase in total
MDA while NAC did not. A reasonable explanation for the modest in-
crease in lipid peroxidation compared to the more pronounced effects
on the other macromolecules became apparent with follow-up mea-
surements of cellular lipid proﬁles. We found PUFA in these cells to
be quite low (7% of total cellular fatty acids; data not shown) and re-
ﬂective of FBS. We found that AGE-BSA did not decrease cell PUFA
percentage. NAC also had no effect on PUFA. Treatment with α-
tocopherol appeared to increase the percent of PUFA, but this effect
was not statistically signiﬁcant. Therefore, the limited lipid peroxida-
tion observed may be due to lack of PUFA targets to form MDA.
Previous studies showed the beneﬁts of hydrophilic antioxidants
like NAC [34], and ﬂavonoid antioxidants like epigallocatechin gallate
(EGCG) [18] on lipid peroxidation under similar experimental condi-
tions. Because EGCG is capable of reducing tocopheroxyl radical back
to tocopherol [35] and GSH can do the same in an ascorbate-
dependent mechanism [36], the observed effects of NAC or ﬂavonoids
on lipid peroxidation may involve recycling of α-tocopherol present
in the cellular membranes. Here, we quantiﬁed basal α-tocopherol
concentrations and those after 200 μM α-tocopherol supplementa-
tion. We observed very low basal α-tocopherol concentrations in
cellular membranes. We suspect that this explains why we did
not see any effect of NAC on AGE-induced MDA formation. With
low α-tocopherol concentrations present in these cells, there is very
little α-tocopherol for GSH synthesized from NAC to recycle via ascor-
bate and thus, NAC is unlikely to aid in preventing lipid peroxidation.
We also found that within cells supplemented with α-tocopherol, BSA
and AGE-BSA-treated cells had signiﬁcantly higher α-tocopherol con-
centrations than PBS-treated cells. BSA may be facilitating α-tocopherol
uptake, which is consistent with the role of albumin as a transporter of
lipids. Glycation of BSA does not affect this process. These ﬁndings fur-
ther demonstrate the critical nature of having a BSA control with such
studies and that BSA – and not PBS –may serve as themost appropriate
control with which to compare the effects of AGE-BSA.
We observed that bothα-tocopherol and NAC suppress protein car-
bonyl formation after AGE administration. NAC efﬁciently inhibited
AGE-induced DNA oxidation, which α-tocopherol also reduced albeit
not completely. Thus, both antioxidants have similar effects in suppres-
sing protein and DNA oxidation. However, NAC signiﬁcantly increased
intracellular GSH while α-tocopherol did not. Therefore, we conclude
that NAC inﬂuences macromolecule oxidation by sustaining the intra-
cellular glutathione pool and potentially through maintaining the re-
duced state of intracellular thiols. In all, both α-tocopherol and
NAC were effective against the oxidation of macromolecules but only
NAC – and not α-tocopherol – is likely to be effective in maintaining
the cellular redox state under AGE stress conditions.
Using DIC microscopy, we documented cell morphological
changes that occur as a result of various AGE treatment combinations.
SH-SY5Y cells were ﬁrst treated for 3–5 days with RA as this increases
expression of tyrosine hydroxylase (TH), a marker of neuronal differ-
entiation (pb0.01, data not shown). Because RA also induces neurite
outgrowth, deterioration of neurite structure due to a particular treat-
ment is more indicative of degeneration mechanisms rather than an
inhibition of outgrowth. While PBS and BSA did not signiﬁcantly af-
fect cell morphology, AGE-BSA negatively inﬂuenced overall mor-
phology with respect to the number of neurites per cell. Additional
experiments qualiﬁed that this is likely not due to loss of a differenti-
ated state of the cells as TH expression in BSA-treated cells and AGE-
BSA-treated cells is not signiﬁcantly different (data not shown).
We then examined if antioxidants can suppress AGE-induced neurite
degeneration. Our data showed that α-tocopherol had no inﬂuence
on neurite deterioration while NAC provided complete protection,
which parallels the effects that these antioxidants have on intra-
cellular GSH. There was no difference between control cells treated
with PBS or BSA and cells treated with AGE-BSA+NAC, thus
Fig. 4. Effects of AGE-BSA and antioxidants on oxidative damage. (A) TBARS for SH-SY5Y cells treated with PBS, BSA, or AGE-BSA±antioxidants for 48 h. Data is expressed as a per-
centage of PBS control. Data were analyzed by ANOVA and bar values are presented as mean±S.D. (n=3). ⁎Pb0.05 vs. BSA control. (B) Analysis of DNPH-derivatized proteins iso-
lated from SH-SY5Y cells treated with PBS, BSA, or AGE-BSA±antioxidants. Data is expressed as a percentage of PBS control. Data were analyzed by ANOVA and bar values are
presented as mean±S.D. (n=3 from 3 independent experiments). ⁎Pb0.001 vs. BSA control. (C) Representative blot of carbonylated proteins from cells treated with PBS (lane
1), BSA (lane 2), AGE-BSA (lane 3), AGE-BSA+200 μM α-tocopherol (lane 4), and AGE-BSA+2 mM NAC (lane 5). (D) Effects of AGE-BSA and antioxidants on DNA oxidation. Con-
focal analysis of anti-8-oxo-2′-deoxyguanosine-staining in SH-SY5Y cells treated with PBS, BSA, or AGE-BSA±antioxidants. Data is expressed as a percentage of PBS control. Data
were analyzed by ANOVA and bar values are presented as mean±S.D. (n=approximately 150 cells from 3 independent experiments). Mean values with superscript letters that are
not the same are signiﬁcantly different (pb0.05).
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generation in this model. Data from several models have shown that
oxidants can either induce neurite degeneration or prevent neurite
outgrowth and that these effects are ameliorated by antioxidants. Ex-
amples include the prevention of lead-induced neurite degeneration
in PC12 cells by selenocystine [37] and the maintenance and promo-
tion of neurite outgrowth by EGCG in serum-starved PC12 cells [38].
α-tocopherol has been studied previously with regard to effects on
neurite outgrowth and maintenance. α-tocopherol supports the sur-
vival and neurite outgrowth for fetal rat brain neurons grown in cul-
ture [39]. α-tocopherol also ameliorates changes in neurite structure
in a mouse model for Alzheimer's disease [40]. In contrast, α-
tocopherol has no effect on α-synuclein-induced neurite retraction
[41]. Therefore, it is likely that the effects of α-tocopherol on neurite
alterations depend on the disease model and the speciﬁc mechanism
of oxidation-induced neurite degeneration.
In this study, we found that α-tocopherol suppresses AGE-induced
macromolecule damage but has no effect on AGE-BSA-induced neurite
degeneration. The thiol antioxidant NACmaintained cellularmorpholo-
gy. This may point toward thiol oxidation as being a primary regulator
of neurite degeneration. Indeed, agents that cause oxidation of tubulin
cysteines induce depolymerization of preformed microtubules [42].
Neurite degeneration caused by oxidative stress is blocked by GSHand L-cysteine, while L-methionine, an amino acid with a sulfur atom
but not a thiol group, has no effect [43]. These data provide evidence
that thiol-containing compounds are effective in reducing neurite de-
generation caused by ROS. Our results further conﬁrm these ﬁndings
as we show here that both α-tocopherol and NAC suppressed AGE-
induced macromolecule damage but only NAC was able to protect
neurite structures under stress conditions. These trends are particularly
important because under some conditions, neurite degeneration
precedes apoptosis and is critically tied to the fate of the cell [44,45].
Therefore, the effect of α-tocopherol on AGE-induced cell death may
be limited by its inability to inﬂuence neurite density.
The implications of this study reach beyond preventive measures
of maintaining nerve integrity in diabetics. Outgrowth of neurite
components within the context of peripheral neuron regeneration is
a vital topic of study for individuals who have already lost a signiﬁ-
cant degree of nerve function. Recent work shows that AGEs contrib-
ute to a limited ability for neuronal regeneration in diabetes [46], but
as we observed in this study, a thiol-containing compound like NAC
may be effective in promoting neurite integrity under stress condi-
tions. We propose that follow-up studies be performed to examine
the role of particular antioxidants in neurite outgrowth under condi-
tions of high glucose or AGE exposure to eventually optimize long-
term outcomes for patients with diabetic neuropathy.
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